Alzheimer's disease innovative drug clinical trial approvals (multi-year total)
RecordSTO-C75C76BR4E-Q5K5NGHX98-66XEJC
China · 2023–2024
Alzheimer's disease innovative drug clinical trial approvals in China (multi-year total) were 8 in 2023–2024 (NMPA).
- Publisher
- NMPA
- Authority tier
- T1 Official
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
In the past two years, it has approved clinical trials for eight innovative drugs that could potentially treat the disease.
Checked: the figure 8is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
National Medical Products Administration. (2024). Measures facilitate approval of 48 first-in-class innovative drugs. Retrieved September 17, 2026, from https://english.nmpa.gov.cn/2025-03/21/c_1080286.htm. Via StatOrigin, https://statorigin.org/stat/stat_C75C76BR4EQ5K5NGHX9866XEJC
Other formats: MLA, Chicago, BibTeX
- MLA
- National Medical Products Administration. "Measures facilitate approval of 48 first-in-class innovative drugs." 2024, https://english.nmpa.gov.cn/2025-03/21/c_1080286.htm. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_C75C76BR4EQ5K5NGHX9866XEJC.
- Chicago
- National Medical Products Administration. "Measures facilitate approval of 48 first-in-class innovative drugs." 2024. https://english.nmpa.gov.cn/2025-03/21/c_1080286.htm. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_C75C76BR4EQ5K5NGHX9866XEJC.
- BibTeX
- @misc{nmpa2024alzheimer66xejc, author = {{National Medical Products Administration}}, title = {Measures facilitate approval of 48 first-in-class innovative drugs}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_C75C76BR4EQ5K5NGHX9866XEJC}, note = {Original source: https://english.nmpa.gov.cn/2025-03/21/c\_1080286.htm. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- National Medical Products Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- Measures facilitate approval of 48 first-in-class innovative drugs
- Type
- Press release
- Published
- —
- Locator
- Measures facilitate approval of 48 first-in-class innovative drugs
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- editorial:judge-fix-v1:2026-09-27
- Checked on
- 27 September 2026
- Last revision
- 27 September 2026
- Permanent URL
- /stat/stat_C75C76BR4EQ5K5NGHX9866XEJC